Literature DB >> 1646759

Epidermal growth factor-related transforming growth factors in the urine of patients with hepatocellular carcinoma.

L Y Chuang1, J H Tsai, Y C Yeh, C C Chang, H W Yeh, J Y Guh, J F Tsai.   

Abstract

To characterize epidermal growth factor-related transforming growth factors in the urine of patients with hepatocellular carcinoma, gel filtration with Bio-Gel P-30 was performed in seven hepatocellular carcinoma patients and seven sex-matched and age-matched healthy controls. Distinct profiles of soft agar growth assay in the hepatocellular carcinoma patients and the normal controls were seen. Three peaks (A, B and C) in the urine were examined. Peak C in most hepatocellular carcinoma patients was higher than that in healthy controls. Similar profiles were detected with epidermal growth factor radioreceptor assay and cellular DNA synthesis assay. This result might indicate that transforming growth factors with low molecular weight were found in the urine of hepatocellular carcinoma patients. An exceptional HCC patient had an additional peak (A') that corresponded to the high molecular weight protein. We concluded that there were transforming growth factors with functional activity in the urine of patients with hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1646759

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.

Authors:  E Santoni-Rugiu; P Nagy; M R Jensen; V M Factor; S S Thorgeirsson
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

2.  Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma.

Authors:  Jen-Eing Jeng; Meng-Feng Tsai; Hey-Ru Tsai; Lea-Yea Chuang; Zu-Yau Lin; Min-Yuh Hsieh; Shinn-Chern Chen; Wan-Lung Chuang; Liang-Yen Wang; Min-Lung Yu; Chia-Yen Dai; Jung-Fa Tsai
Journal:  Tumour Biol       Date:  2013-12-30

Review 3.  Hepatocellular carcinoma: Review of disease and tumor biomarkers.

Authors:  Jin Un Kim; Mohamed I F Shariff; Mary M E Crossey; Maria Gomez-Romero; Elaine Holmes; I Jane Cox; Haddy K S Fye; Ramou Njie; Simon D Taylor-Robinson
Journal:  World J Hepatol       Date:  2016-04-08

4.  Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma.

Authors:  J F Tsai; J E Jeng; L Y Chuang; M L Yang; M S Ho; W Y Chang; M Y Hsieh; Z Y Lin; J H Tsai
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.

Authors:  J F Tsai; J E Jeng; L Y Chuang; M L Yang; M S Ho; W Y Chang; M Y Hsieh; Z Y Lin; J H Tsai
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 6.  Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers.

Authors:  Francesca M Trovato; Joshua M Tognarelli; Mary Me Crossey; Daniela Catalano; Simon D Taylor-Robinson; Guglielmo M Trovato
Journal:  World J Hepatol       Date:  2015-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.